Trump Just Took a Hatchet to the FEC
Jen Psaki's Faux Platner Outrage
More Platner Grappling in the Press; An ICE Shooting Has the Bulwark Gang...
Democrats Unanimously Opposed the Working Families Tax Cuts. Now They're Trying to Take...
250 Years After Independence, New Index Asks Whether Government Is Stifling America's Char...
Here's the Problem With Modern-Day Immigration, According to Milton Friedman
DOJ Sues Maryland Over Sanctuary Policies Blocking Immigration Enforcement
NH Casino Owner Pleads Guilty to Stealing $255K in COVID-19 Relief Funds
Boston Accounting Firm Owner Sentenced in $1.6 Million Under-the-Table Pay Scheme
The United States Is Still Talking to Iran After Big Strikes
West Virginia Woman Pleads Guilty to Stealing $160K From Disabled Veteran
This Canadian Woman Just Exposed the Fatal Flaws of Universal Healthcare
Boston Store Owner Sentenced After $7 Million SNAP Fraud Scheme
Susan Collins Already Defeated One of Her Possible Democrat Challengers
Talarico Has Another Tenet of His Fake Christianity
Tipsheet

'Revolving Door': What the WH Left Out of Its Announcement About Nominee for NIH Director

'Revolving Door': What the WH Left Out of Its Announcement About Nominee for NIH Director

President Biden on Monday nominated Dr. Monica Bertagnolli, a surgical oncologist and head of the National Cancer Institute, to be the next director of the National Institutes of Health, but critics say the White House left out an important detail about her background in the administration’s announcement.  

Advertisement

“Dr. Bertagnolli has spent her career pioneering scientific discovery and pushing the boundaries of what is possible to improve cancer prevention and treatment for patients, and ensuring that patients in every community have access to quality care,” Biden said in a statement.
 
“As Director of the National Cancer Institute, Dr. Bertagnolli has advanced my Cancer Moonshot to end cancer as we know it. She has brought together partners and resources from different sectors to launch groundbreaking efforts in cancer prevention and early detection, a national navigation program for childhood cancers, and additional programs to bring clinical trials to more Americans,” the statement continued. “Dr. Bertagnolli is a world-class physician-scientist whose vision and leadership will ensure NIH continues to be an engine of innovation to improve the health of the American people.” 

As Democratic presidential candidate Robert F. Kennedy Jr. and others pointed out, she’s a “revolving door” nominee. 

“From 2015-2021, Bertagnolli received more than 116 grants from Pfizer, totaling $290.8 million. This amount made up 89% of all her. research grants,” he tweeted. 

Kennedy was sure to point out this doesn’t automatically make her “personally corrupt,” but that she will champion Big Pharma’s viewpoints.  

Advertisement

“That is how agencies are captured,” he added, commenting later that he was not surprised the White House left this detail out of the announcement. 


Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement